Resultz
Commercial- Indications
- Head lice infestation
Company intelligence / Profile preview
Heumann Pharma
Nürnberg, Bayern, Germanyheumann.de ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
As of 2023, over 16 million packs of Heumann prescription medicines were distributed to patients[2]
- Therapeutic areas
- Other
- Modalities
- Generic medicinesprescription medicinesover-the-counter medicines
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Contracts with statutory and private health insurance companies for about 86% of their prescription medicines[2]
Beyond the preview
Go deeper on Heumann Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Heumann Pharma.